Introduction {#s1}
============

Most of us spend nearly a third of life in sleep, though the mechanisms underlying sleep remain unclear. Circadian rhythm and homeostasis can separately and interactively regulate sleep and wakefulness ([@bib7]; [@bib8]). Research in drosophila and other organisms has revealed the molecular mechanisms of the circadian clock (reviewed in [@bib63]\]). By contrast, less is known about the molecular mechanisms controlling sleep homeostasis.

The development of drosophila as a model animal to study sleep ([@bib33]; [@bib78]) has led to findings of multiple genes that are important for sleep ([@bib1]; [@bib11]; [@bib13]; [@bib14]; [@bib16]; [@bib17]; [@bib20]; [@bib22]; [@bib30]; [@bib40]; [@bib43]; [@bib45]; [@bib46], [@bib49]; [@bib55]; [@bib58]; [@bib64]; [@bib65]; [@bib82]; [@bib86]; [@bib87]; [@bib88]; [@bib89]; [@bib90]; [@bib99]), whereas less is known about sleep homeostasis, operationally defined as sleep rebound after deprivation. Molecular components that are implicated in sleep homeostasis include cyclic AMP, *CREB*, *sleepless*, *cyc*, *Hsp83*, *Cullin-3* and *cyclin A* ([@bib14]; [@bib22]; [@bib40]; [@bib73]; [@bib79]; [@bib87]; [@bib92]). The lLNv and DN1 clock neurons are important for circadian control of sleep ([@bib2]; [@bib13]; [@bib31]; [@bib49]; [@bib64]) while the ellipsoid body (EB), the mushroom bodies (MB) and the ExFl2 neurons projecting to dorsal fan-shaped body (dFB) are important for sleep homeostasis ([@bib20]; [@bib50]; [@bib66]; [@bib85]). dFB neurons alter their excitability in response to sleep deprivation, which is mediated by a specific Rho-GTPase-activating protein (Rho-Gap), *crossveinless-c* ([@bib20]). R2 neurons in the EB act upstream of dFB and specifically generate sleep drive ([@bib50]). Neurotransmitters are known to be involved in regulating sleep in mammals ([@bib59]). In flies, thermogenetic activation of a small subset of cholinergic neurons promotes sleep and elicits sleep homeostasis, whereas activation of octopaminergic neurons promotes sleep but suppresses sleep homeostasis ([@bib77]).

Serotonin or 5-hydroxytryptamine (5-HT) is involved in multiple behaviors in drosophila, including learning and memory, feeding, courtship and aggression ([@bib6]; [@bib18]; [@bib36]; [@bib47]; [@bib83]; [@bib99]). The *5HT1a* receptor is important for sleep: *5HT1a* mutant flies had reduced and fragmented sleep ([@bib99]). However, the involvement of 5-HT in sleep homeostasis is unclear.

Results {#s2}
=======

Investigation of the serotonergic system in drosophila {#s2-1}
------------------------------------------------------

5-HT is synthesized in two steps: the conversion of tryptophan to 5-hydroxytryptophan (5HTP) by tryptophan hydroxylase (Trh in flies and Tph in mammals) ([@bib42]), followed by the conversion of 5HTP to 5-HT by aromatic amino acid decarboxylase ([Figure 1A](#fig1){ref-type="fig"}). We have generated genetic tools that allow systematic studies of the serotonergic system. Four receptors were known to be 5-HT receptors in drosophila when we started this project: *5HT1a*, *5HT1b*, *5HT2* and *5HT7* ([@bib15]; [@bib75]; [@bib93]). Our bioinformatics analysis had revealed a new G-protein- coupled receptor (GPCR), annotated as *CG42796* in the drosophila genome, as a new 5-HT receptor which we named as *5HT2b,* with the previously known *5HT2* becoming *5HT2a* ([@bib9]; [@bib25]). 5HT2b was predicted to be coupled to Gq protein and shown in our collaboration to mediate 5-HT responsiveness ([@bib25]).

![Sleep in Trh and 5-HT receptor mutants.\
(**A**) 5-HT synthesis in the brain. (**B--D**) Three strategies used in constructing drosophila lines. (**B**) The end-out method. All five receptor mutants were constructed by this method. (**C and D**) The CRISPR/Cas9 system was used to delete target DNA and/or to insert DNA. *Gal4*, *Flp* or *LexA* were introduced at specific locations, such as the beginning of the first exon (**C**), or the end of the open reading frame (ORF) with the 2a peptide as linker (**D**). (**E**) Sleep profiles over four consecutive days, the first two days were in 12 hr light/12 hr dark (LD) cycle, and last two days in constant darkness (DD). (**F--H**) *Trh*, *5HT1a* and *5HT2b* mutant flies slept less than wild type (wt) controls. Sleep bout durations in LD are shown for: nighttime (**F**), daytime (**G**) and whole 24 hour day (**H**). (**I**) Sleep bout duration was reduced in Trh^01^, Trh^GKO^, *5HT1a* and *5HT2b* mutants during LD. (**J**) Latency after light-off was delayed in Trh^01^, Trh^GKO^, *5HT1a* and *5HT2b* mutants. (**K**) All mutants showed normal activity when awake, as measured by locomoter distance per waking min. (B--K, mean ± SEM, n = 48 for WT, n = 37 for *5HT1a* mutants, n = 48 for *5HT1b* mutants, n = 45 for *5HT2a* mutants, n = 40 for *5HT2b* mutants, n = 48 for 5HT7 mutants, n = 43 for Trh^01^ mutants, and n = 48 for Trh^GKO^ mutant).](elife-26519-fig1){#fig1}

We constructed knockout and knockin lines for Trh and all the five receptors for 5HT in drosophila. The ends-out gene targeting strategy was used to generate null mutants ([@bib35]; [@bib74]) (Strategy I) ([Figure 1B](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A and B](#fig1s1){ref-type="fig"}). To visualize gene expression and to manipulate neuronal activity, we generated *Gal4*, *LexA* or *Flp* knock-in lines for each of these genes using the CRISPR/CAS9 method, with *Gal4*, *LexA* or *Flp* introduced at the starting sequence of the first exon (Strategy II) or at the end of the open reading frame (Strategy III) ([Figure 1C and D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1C and D](#fig1s1){ref-type="fig"}). Using Strategy II, we obtained null mutants with *Gal4*/*Flp*/*LexA* replacing the targeted gene, which provided strains that allowed us to manipulate neurons in mutants lacking specific genes. Strategy III enabled us to visualize the expression of specific genes faithfully and manipulated neurons without interrupting gene function and expression. The genotypes of constructed lines were confirmed by polymerase chain reaction (PCR) and sequencing ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

We also constructed an indel mutant for *Trh* (Trh^01^) with a guide RNA targeting the catalytic center of the enzyme and deleting two basepairs ([Figure 1---figure supplement 1E--F](#fig1s1){ref-type="fig"}), which caused an early translational stop ([Figure 1---figure supplement 1G](#fig1s1){ref-type="fig"}). No 5-HT was detected in the brains of Trh^01^ or Trh^GKO^mutants (generated by Strategy II, *Gal4* insertion and replacement of gene), although it was detected in the brains of the wild type (wt) or Trh::Gal4 (generated by Strategy III) flies ([Figure 1---figure supplement 2A--D](#fig1s2){ref-type="fig"}).

5-HT regulation of sleep through both the 5HT2b and 5HT1a receptors {#s2-2}
-------------------------------------------------------------------

We analyzed the sleep patterns of *Trh* and 5-HT receptor mutants ([Figure 1E](#fig1){ref-type="fig"}). *Trh*, *5HT1a* or *5HT2b* mutant flies were found to sleep less than the wt in both 12 hr (hr) light/12 hr dark (LD) cycles and in constant darkness (DD) ([Figure 1F--H](#fig1){ref-type="fig"}, [Figure 1---figure supplement 3A--C](#fig1s3){ref-type="fig"}). These three mutants exhibited reduced sleep bout duration during the day and night ([Figure 1I](#fig1){ref-type="fig"}), and also in DD phase ([Figure 1---figure supplement 3D and E](#fig1s3){ref-type="fig"}). *Trh*, *5HT1a* and *5HT2b* mutants also displayed prolonged latency to sleep at night ([Figure 1J](#fig1){ref-type="fig"}). *Trh*, *5HT1a* and *5HT2b* mutants showed no change in the intensity of locomotor activity when awake ([Figure 1K](#fig1){ref-type="fig"}). As reported previously, *5HT1a* mutant flies had reduced sleep ([@bib99]). The sleep phenotype of *5HT2b* mutants was much more severe than that of *5HT1a* mutants, nearly equal to that of *Trh* mutants ([Figure 1E and H](#fig1){ref-type="fig"}). In DD, *5HT2b* mutants showed a large decrease in sleep duration and sleep bout duration in both the subjective daytime and the subjective nighttime ([Figure 1---figure supplement 3A--C](#fig1s3){ref-type="fig"}). Results in males were similar to those in females except that male *5HT1b* mutants exhibited decreased sleep during the daytime of LD but not during DD ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). These results indicated that *5HT2b* functions to promote sleep. The difference between LD and DD was consistent with the abnormal light sensitivity of *5HT1b* mutants as reported previously ([@bib98]).

To test whether 5-HT functions directly in adult flies or indirectly during development, we restored 5-HT level in *Trh* mutant flies by feeding adults with 5HTP, which could circumvent the requirement for *Trh*. Two mg/ml 5HTP for 3 days restored 5HT immunofluorescence in the brains of Trh^01^ and Trh^GKO^ flies ([Figure 1---figure supplement 2E--H](#fig1s2){ref-type="fig"}). 5-HTP feeding rescued both daytime and nighttime sleep in 5HTP to Trh^01^ mutants ([Figure 1---figure supplement 2I and J](#fig1s2){ref-type="fig"}) and in Trh^GKO^ mutants (data not shown) to about wt level, indicating that 5-HT promotes sleep in adult flies.

5-HT regulation of sleep recovery after deprivation through the 5HT2b receptor {#s2-3}
------------------------------------------------------------------------------

The involvement of 5-HT in circadian rhythm has been reported previously ([@bib61]; [@bib62]; [@bib71]; [@bib98]). We first analyzed free-running locomotor rhythms to distinguish between the roles of serotonin signaling in circadian and homeostatic sleep regulation. We have not observed circadian period changes in any of our mutants when compared to the wt in the same genetic background after entrainment to a 12 hr (hr) light/12 hr dark (LD) cycle for 3 days, followed by analysis in constant darkness (DD) for 12 days ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Next, we investigated whether 5-HT regulated sleep homeostasis. We deprived flies of sleep for a whole night with approximately 100% efficiency ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), and measured sleep recovery over the ensuing 48 hr. Wt flies regained their lost sleep and completely recovered during the first 24 hr ([Figure 2---figure supplement 3C](#fig2s3){ref-type="fig"}). *Trh* and *5HT2b* mutants exhibited a significantly lower percentage of sleep recovery rate than wt flies ([Figure 2A and B](#fig2){ref-type="fig"}). For weaker sleep deprivation, these mutants also showed impaired sleep recovery ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). However, *5HT1a* mutant flies, though defective in sleep, were similar to the wt and mutants of any other serotonergic receptors in showing normal sleep recovery after sleep deprivation ([Figure 2A and B](#fig2){ref-type="fig"}), further supporting the hypothesis that involvement in regulating total sleep time is separate from involvement in regulating sleep recovery after deprivation. To test whether 5-HT functions to control sleep homeostasis in adult flies and not through indirect actions during development, we fed 5-HTP to adult flies. We found that 5HTP restored sleep homeostasis in *Trh* mutant flies to the normal level ([Figure 2C and D](#fig2){ref-type="fig"}).

![Sleep homeostasis in *Trh* and 5-HT receptor mutants.\
(**A**) *Trh* and *5HT2b* mutant flies regained a lower percentage of lost sleep time than wt after 12-hr overnight sleep deprivation. Other receptor mutants showed normal recovery rate after sleep deprivation. (**B**) Statistical analysis of sleep rebound after 24-hr recovery (mean ± SEM, n = 39 for wt, n = 38 for *5HT1a* mutants, n = 38 for *5HT1b* mutants, n = 38 for *5HT2a* mutants, n = 45 for *5HT2b* mutants, n = 47 for *5HT7* mutants, n = 44 for Trh^01^ mutants, and n = 42 for Trh^GKO^ mutants, respectively). (**C**) Sleep recovery rate after sleep deprivation. Three-day feeding of 2 mg/ml 5HTP did not change sleep recovery in wt flies, but rescued sleep rebound in Trh^01^ and Trh^GKO^ flies. (**D**) Statistical analysis (mean ± SEM, n = 47 for wt with H~2~O, n = 34 for Trh^01^ with H~2~O, n = 34 for Trh^GKO^ with H~2~O, n = 48 for wt with 5HTP, n = 36 for Trh^01^ with 5HTP, and n = 45 for Trh^GKO^ with 5HTP). (**E--G**) Sleep profiles after thermogenetical activation of dopaminergic neurons in wt (**E**), *Trh* mutant (**F**), or *5HT2b* mutant flies (**G**). (**H**) Sleep loss during neural activation. (**I**) Sleep gain over 24 hr after thermogenetically induced sleep deprivation. (**J**) Statistical analysis of sleep rebound after 24-hr recovery. (E--J, n = 32--48 for each strain). One-way ANOVA was used to detect statistical difference between different genotypes. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001.](elife-26519-fig2){#fig2}

Previous studies have shown that the activation of specific neurons could cause sleep deprivation ([@bib21]; [@bib77]). We took advantage of this to induce sleep loss thermogenetically by expressing transgenic TrpA1 channels (UAS-TrpA1) in dopaminergic neurons (TH-Gal4). We measured the sleep loss, sleep gain and recovery rate in wt, *Trh* mutant and *5HT2b* mutant flies after sleep loss induced by activation of dopaminergic neurons. *Trh* and *5HT2b* mutant flies showed impaired sleep recovery when compared to wt flies ([Figure 2E--J](#fig2){ref-type="fig"}). Thus, our results indicate that 5-HT and its 2b receptor regulate sleep homeostasis in adult flies, independent of the methods of sleep deprivation.

Expression patterns of *Trh* and *5HT2b* genes {#s2-4}
----------------------------------------------

To visualize the patterns of *Trh* or *5HT2b*, we crossed flies carrying Trh::Gal4 and 5HT2b::Gal4 (both generated by Strategy III) with flies carrying UAS-mCD8GFP for labeling of the cytoplasmic membrane of cells expressing each gene ([Figure 3A and E](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1F and J](#fig3s1){ref-type="fig"}), UAS-stingerGFP for nuclear labeling ([Figure 3B and F](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1G and K](#fig3s1){ref-type="fig"}), UAS-DscamGFP for dendritic labeling ([Figure 3C and G](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1H and L](#fig3s1){ref-type="fig"}) or UAS-sytGFP for axonal labeling ([Figure 3D and H](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1I and M](#fig3s1){ref-type="fig"}). *Trh-* and *5HT2b*-positive neurons were found in the brain and the ventral nerve cord (VNC). Trh::Gal4 labeled all of the previously reported 5-HT clusters in the adult brain: Anterior lateral protocerebrum (ALP), Anterior medial protocerebrum (AMP), Anterior dorsomedial protocerebrum (ADMP), Lateral protocerebrum (LP), Lateral subesophageal ganglion (SEL) and Medial subesophageal ganglion (SEM) anterior clusters; Posterior lateral protocerebrum (PLP), Posterior medial protocerebrum, dorsal (PMPD), Posterior medial protocerebrum, medial (PMPM) and Posterior medial protocerebrum, ventral (PMPV) posterior clusters ([@bib4]; [@bib68]; [@bib83] , [@bib84]; [@bib91]) and showed similar expression pattern when compared to reported transgenic strains ([@bib4]). The distribution of the axons and dendrites of neurons that were positive for Trh::Gal4 could be found in the optic lobe, the olfactory lobe, the central complex and the mushroom bodies (MBs) ([Figure 3C and D](#fig3){ref-type="fig"}, [Video 1](#video1){ref-type="video"}).

![Expression patterns of *Trh* and *5HT2b* genes in the brain.\
(**A--D**) Brains of UAS-mCD8GFP; Trh::Gal4 (**A**), UAS-stingerGFP; Trh::Gal4 (**B**), UAS-DscamGFP; Trh::Gal4 (**C**) and UAS-sytGFP; Trh::Gal4 (**D**) flies immunostained with the anti-GFP antibody (green) and the neuropil marker nc82 antibody (red). (**E--H**) Brains of UAS-mCD8GFP; 5HT2b::Gal4 (**E**), UAS-stingerGFP; 5HT2b::Gal4 (**F**), UAS-DscamGFP; 5HT2b::Gal4 (**G**) and UAS-sytGFP; 5HT2b::Gal4 (**H**), immunostained with anti-GFP antibody (green) and nc82 antibody (red).](elife-26519-fig3){#fig3}

###### Expression pattern of the *Trh* gene.

About 200 neurons were labeled in the brain. The neural projections were found in optic lobes, olfactory lobes central complex, subesophageal ganglion and mushroom bodies.

10.7554/eLife.26519.013

5HT2b::Gal4 labeled more than 500 neurons in the brain ([Figure 3E and F](#fig3){ref-type="fig"}). The axons and dendrites were found in the central complex, the olfactory lobe, the optic lobe, the subesophageal ganglion and the ventrolateral protocerebrum, but not the MBs ([Figure 3G and H](#fig3){ref-type="fig"}, [Video 2](#video2){ref-type="video"}). A recent study of *5HT2b* expression using the MiMIC system labeled the same brain regions and showed a similar expression pattern ([@bib28]). We also examined the expression patterns of Trh^GKO^, 5HT2b^GKO^ (generated by Strategy II, Gal4 insertion and replacement) and 5HT2b-LexA (generated by Strategy II, LexA insertion and replacement), and found patterns of expression similar to that of the Gal4 line generated by Strategy III ([Figure 3---figure supplement 1A--E](#fig3s1){ref-type="fig"}).

###### Expression pattern of the *5HT2b* gene.

More than 500 neurons were labeled in the brain. The neural projections were found in the central complex, the olfactory lobe, the optic lobe, the subesophageal ganglion and the ventrolateral protocerebrum, but not in the MBs.

10.7554/eLife.26519.014

Expression of *5HT2b* in a pair of dFB neurons {#s2-5}
----------------------------------------------

Previous studies have implicated different brain regions, such as the MB ([@bib37]; [@bib67]; [@bib85]), the dFB ([@bib19][@bib20]; [@bib48]; [@bib66]; [@bib90]), large ventral lateral clock neurons (lLNv) ([@bib13]), dorsal neurons (DN1) ([@bib31]; [@bib44]), the ellipsoid body (EB) ([@bib50]), and the pars intercerebralis (PI) ([@bib17]) in controlling sleep duration and homeostasis ([Figure 4A](#fig4){ref-type="fig"}). We used the intersectional strategy to examine whether *5HT2b* was expressed in any of these regions. Sparse expression was found in the MB and extensive expression in the dFB when 5HT2b-LexA strains were combined with LexAop-Flp, UAS-FRT-stop-FRT-mCD8GFP and different region-specific Gal4 lines ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). To further confirm the functional roles of the *5HT2b* gene, we expressed *5HT2b* RNA interference (RNAi) in 5HT2b neurons and different brain regions. RNAi efficiency was validated by qRT-PCR ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). RNAi-mediated knockdown of either 5HT2b or dFB neurons reduced sleep relative to controls, whereas knockdown of *5HT2b* in other regions had no significant effect ([Figure 4A](#fig4){ref-type="fig"}). 23E10-GAL4 and 23E10-LexA lines labeled approximately 40 neurons projecting their axons to the dFB ([Figure 4B and C](#fig4){ref-type="fig"}) ([@bib20]; [@bib54]). Two to four dFB neurons were labeled on each side of the adult fly with intersection of 5HT2b and 23E10 ([Figure 4D and E](#fig4){ref-type="fig"}, [Video 3](#video3){ref-type="video"}). We also used 23E10-Gal4 and 5HT2b-LexA to drive the expression of UAS-StingerGFP and LexAop-tdTomato separately ([Figure 4F](#fig4){ref-type="fig"}). Only a single dFB neuron on each side of the adult fly was positive for both green fluorescent protein (GFP) and red fluorescent protein (RFP) ([Figure 4G and H](#fig4){ref-type="fig"}). They constitute a single pair of 5HT2b-positive neurons in the dFB.

![A single pair of dFB neurons expressing *5HT2b*.\
(**A**) Schematic illustration of different brain regions regulating sleep (above). dFB, dorsal fan-shaped body; DN1, dorsal neurons 1; lLNv, large ventral lateral clock neurons; MB, mushroom body; PI, pars intercerebralis. Sleep in flies expressing different Gal4-driven *5HT2b* RNAi lines (below). (**B**) Brain of UAS-mCD8GFP; 23E10-Gal4 flies, immunostained with the anti-GFP antibody (green) and the nc82 antibody (red). (**C**) Brain of UAS-DenMark,UAS-sytGFP; 23E10-Gal4 fly, immunostained with the anti-GFP antibody (green), the anti-RFP antibody (red) and the neuropil marker nc82 antibody (blue). (**D and E**) Intersectional neurons of 23E10 and 5HT2b. Brain of 23E10-LexA/UAS-FRT-mCD8GFP-FRT; LexAop-Flp/Trh::Gal4 fly, immunostained with the anti-GFP antibody (green) and the neuropil marker nc82 antibody (red). Two intersectional neurons were labeled (**E**). (**F--H**) One pair of 5HT2b and 23E10 co-stained neurons. 5HT2b-LexA driven LexAop-tdTomato labelled 5HT2b neurons after anti-RFP immunostaining, and 23E10-Gal4 driven UAS-stingerGFP labelled 23E10 neurons after anti-GFP immunostaining. (F1, G1, and H1) Whole-mount staining. (F2, G2, and H2) Cell bodies of two co-stained neurons. NC82 fluorescences blue. Arrows indicate the cell bodies of co-stained neurons. (**I--K**) Immunostainings of 5HT2b^sfGFP^ and serotonin. 5HT2b^sfGFP^ labelled green, 5-HT labelled red and NC82 labelled blue as background. (I1, J1, and K1) Whole-mount staining. (I2, J2, and K2) Slice of FB region staining. (**L--N**) Immunostaining of 5HT2b^sfGFP^ at dFB and serotonin. UAS-5HT2b^sfGFP^ driven by 23E10 labelled green, 5HT labelled red and NC82 labelled blue as background. (L1, M1, and N1) Whole-mount staining. (L2, M2, and N2) Slice of FB region.](elife-26519-fig4){#fig4}

###### 23E10 and 5HT2b intersectional neurons.

Two pairs of 23E10 and 5HT2b intersectional neurons in the brain.

10.7554/eLife.26519.017

To visualize 5HT2b protein expression, we constructed a 5HT2b protein-trap knockin strain by fusing a superfolder GFP to the carboxyl terminus of 5HT2b protein ([@bib70]). We found the pattern of protein expression to be similar to that of *5HT2b* gene expression ([Figure 3E](#fig3){ref-type="fig"} and [Figure 4J](#fig4){ref-type="fig"}). We also found both strong anti-serotonin immunofluorescence and 5HT2b^sfGFP^ staining signal in the dorsal FB region ([Figure 4I--K](#fig4){ref-type="fig"}). To determine whether the ExFl2 neurons contribute to the 5HT2b^sfGFP^ staining signal in the dorsal FB region, we crossed UAS-5HT2b^sfGFP^ to 23E10-Gal4, and found strong GFP in the presynaptic region of ExFl2 neurons, but not in the postsynaptic region nor in the cell body ([Figure 4L--N](#fig4){ref-type="fig"}). These results suggest that the 5HT2b receptor is located presynaptically in ExFl2 neurons.

Manipulation of 5HT2b and dFB intersectional neurons regulates sleep duration and homeostasis {#s2-6}
---------------------------------------------------------------------------------------------

Artificial activation of dFB neurons induces sleep ([@bib19]; [@bib90]), whereas silencing of them reduces sleep ([@bib41]; [@bib48]). We confirmed these results by activating 23E10-labeled dFB neurons with UAS-Nachbach ([@bib53]), which used a bacterial sodium channel to increase neuronal excitability ([Figure 5---figure supplement 1A and B](#fig5s1){ref-type="fig"}). We crossed 23E10-Gal4 with UAS-head involution defective (UAS-Hid), expressing a protein causing cell death ([@bib100]), to ablate the 23E10 neurons ([Figure 5---figure supplement 1C and D](#fig5s1){ref-type="fig"}). Sleep duration was reduced in flies in which 23E10 neurons were ablated ([Figure 5---figure supplement 1E and F](#fig5s1){ref-type="fig"}). Flies without 23E10 neurons lost sleep homeostasis: showing no sleep rebound after 12-hr overnight sleep deprivation ([Figure 5---figure supplement 1G and H](#fig5s1){ref-type="fig"}).

We next tested the roles of 5HT2b- and dFB- intersectional neurons. We used Gal80 driven by the *Tublin* promoter to suppress 23E10-Gal4-driven expression of UAS-mCD8GFP, or of effectors such as Nachbach and Hid, with the Gal80 gene flanked by FRT recombination sites (FLP-out Gal80; Tub-FRT-Gal80-FRT). Gal80 could efficiently suppress Gal4 expression ([Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}). When combined 5HT2b-LexA was used to drive the expression of LexAop-Flp, FLP-mediated recombination caused GAL80 to be flipped out, resulting in Gal4 expression in Flp-containing 5HT2b neurons. Consequently, GAL4 was effective exclusively in 5HT2b and 23E10 intersectional neurons ([Figure 6---figure supplement 1A and B](#fig6s1){ref-type="fig"}) ([@bib29]). Sleep was greatly increased after 23E10 and 5HT2b intersectional neurons were activated ([Figure 5A--C](#fig5){ref-type="fig"}). Sleep was reduced in flies in which 23E10 and 5HT2b intersectional neurons were ablated ([Figure 5A--C](#fig5){ref-type="fig"}). Sleep homeostasis was impaired after ablation of 23E10 and 5HT2b intersectional neurons ([Figure 5D--F](#fig5){ref-type="fig"}).

![Effect of manipulating 5HT2b and dFB intersectional neurons on sleep.\
(**A**) Schematic illustration of the genetic manipulation of 5HT2b and dFB neurons for sleep analysis. (**B--C**) Activation of 5HT2b and 23E10 intersectional neurons increased sleep, and ablation of these neurons reduced sleep. Sleep profiles for flies with 23E10 neuron activation and control flies for 24 hr (**B**). Flies with neural activation slept more whereas those with ablation slept less . (**C**). Mean ± SEM, n = 48 for I, n = 48 for II, n = 48 for III, n = 48 for IV, n = 47 for V and n = 41 for VI flies. (**D**) Schematic illustration of genetic manipulation of 5HT2b and dFB neurons for sleep homeostasis analysis. (**E--F**) Ablation of 23E10 neurons impaired sleep rebound. Flies with 5HT2b and 23E10 intersectional neuron ablation had abnormal recovery rate after 12-hr sleep deprivation (mean ± SEM, n = 32 for I, n = 35 for II, n = 44 for III, and n = 40 for IV). Statistical analysis was performed with one-way ANOVA: \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001.](elife-26519-fig5){#fig5}

Sufficiency of *5HT2b* gene in dFB neurons for sleep homeostasis {#s2-7}
----------------------------------------------------------------

To examine whether the 5HT2b receptor functions in dFB neurons, we restored *5HT2b* cDNA to *5HT2b* knockout mutant flies by UAS-5HT2b ([Figure 6A](#fig6){ref-type="fig"}). 5HT2b^GKO^ is a Gal4 KI line generated by Strategy II which was used to drive the expression of 5HT2b cDNA in all 5HT2b neurons, whereas 23E10 Gal4 was used to drive 5HT2b expression in dFB neurons ([Figure 6A](#fig6){ref-type="fig"}). Both significantly increased sleep duration at nighttime but neither affected daytime sleep ([Figure 6B and C](#fig6){ref-type="fig"}), indicating that *5HT2b* in dFB neurons is sufficient to promote nighttime sleep. Sleep recovery after 12-hr deprivation in *5HT2b* mutant flies was rescued by either *5HT2b* expression in all *5HT2b* positive neurons or *5HT2b* expression in 23E10 neurons ([Figure 6D and E](#fig6){ref-type="fig"}). We also used RNAi knockdown of the *5HT2b* gene in dFB neurons to test the necessity of *5HT2b*. A dFB gene knockdown strain showed shortened sleep duration and impaired sleep homeostasis ([Figure 6K--O](#fig6){ref-type="fig"}). These results indicate that 5HT2b in dFB neurons is sufficient to regulate sleep homeostasis.

![Regulation of sleep and sleep homeostasis by the *5HT2b* gene in one pair of dFB neurons.\
(**A**) Schematic illustration of genetic rescue with *5HT2b* cDNA in *5HT2b* mutants. (**B**) Sleep profile for 5HT2b homozygous heterzygous mutants and genetic rescue lines with 5HT2b^GKO^ or 23E10-Gal4. (**C**) *5HT2b* mutants slept less than wt or genetic rescue stains with 5HT2b^GKO^ or 23E10-Gal4 (mean ± SEM, n = 48 for I, n = 48 for II, n = 48 for III, n = 848 for IV, n = 32 for V and n = 48 for VI). (**D and E**) Heterozygous mutants and flies with *5HT2b* cDNA restored in 5HT2b or 23E10 neurons had normal recovery rate after 12-hr sleep deprivation (**D**). (**E**) Statistical analysis (mean ± SEM, n = 43 for I, n = 47 for II, n = 36 for III, n = 25 for IV, n = 31 for V and n = 33 for VI). (**F**) Schematic illustration of genetic rescue in 5HT2b but not 23E10 neurons. (**G**) Sleep profile for the *5HT2b* homozygous mutant and genetic rescue in 5HT2b neurons and genetic rescue lines in all 5HT2b neurons but not in 23E10 neurons. 5HT2b mutant flies and flies with 5HT2b rescue in all 5HT2b neurons but not in 23E10 neurons were similar in sleep duration during both days and nights, but slept less than genetic rescue strains with 5HT2bGKO in night-time sleep (**G**). (**H**) Statistical analysis (mean ± SEM, n = 48 for I, 48 for II, and 46 for III, respectively). (**I--J**) *5HT2b* mutant flies and flies with *5HT2b* rescue in all 5HT2b neurons but not 23E10 neurons showed impaired sleep homeostasis (**I**). (**J**) Statistical analysis (mean ± SEM, n = 41 for I, n = 40 for II, and n = 43 for III). (**K**) Schematic illustration of *5HT2b* gene knockdown in 23E10 neurons or in all *5HT2b* neurons but not 23E10 neurons. (**L**) Sleep profile for strains of *5HT2b* gene knockdown 23E10 neurons and Gal80 rescue in 23E10 neurons. Gene knockdown in dFB neurons showed shortened sleep duration (II), and the Gal80 rescued strain (V) showed normal sleep duration. (**M**) Statistical analysis (mean ± SEM, n = 46 for I, n = 42 for II, n = 43 for III, n = 48 for IV and n = 44 for V). (**N--O**) Gene knockdown in dFB neurons showed abnormal sleep homeostasis, and the Gal80 rescued strain (V) was able to restore the sleep homeostasis. (**O**) Statistical analysis (mean ± SEM, n = 43 for I, n = 30 for II, n = 37 for III, n = 48 for IV and n = 35 for V). One-way ANOVA was used to detect statistical difference between different genotypes. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001.](elife-26519-fig6){#fig6}

Requirement for *5HT2b* gene in a pair of dFB neurons for sleep homeostasis {#s2-8}
---------------------------------------------------------------------------

To determine whether a single pair of dFB neurons that were positive for the *5HT2b* receptor were necessary for sleep homeostasis, we used 5HT2b^GKO^ to drive the expression of 5HT2b cDNA in all 5HT2b neurons, but with 23E10-LexA to drive the expression of LexAop-Gal80, thus suppressing *5HT2b* expression in only one pair of dFB neurons ([Figure 6F](#fig6){ref-type="fig"}). Dual reporters for 23E10 and 5HT2b were used to test the efficiency of Gal80 suppression, which revealed a single pair of neurons that were positive for both 23E10 and 5HT2b ([Figure 6---figure supplement 1D and E](#fig6s1){ref-type="fig"}), but no double-positive neurons in the presence of LexAop-Gal80 ([Figure 6---figure supplement 1F and G](#fig6s1){ref-type="fig"}), indicating that the Gal4 was efficiently suppressed in the dFB by LexA-Gal80. This allowed us to express *5HT2b* in all *5HT2b-*positive neurons except this single pair of dFB neurons. The sleep duration of flies in which 5HT2b^GKO^ drove the expression of *5HT2b* cDNA in all 5HT2b neurons. except one pair of dFB neurons, in the *5HT2b* knockout background was significantly decreased, to a level similar to that of the *5HT2b* knockout mutants ([Figure 6G and H](#fig6){ref-type="fig"}). Furthermore, flies lacking *5HT2b* receptor in dFB neurons had no sleep recovery after 12-hr deprivation ([Figure 6I and J](#fig6){ref-type="fig"}). In addition, we rescued the expression of *5HT2b* with Gal80 in dFB neurons in the background of *5HT2b* knockdown to test the sufficiency of *5HT2b*. Both sleep duration and homeostasis were restored in this strain ([Figure 6K--O](#fig6){ref-type="fig"}). These results indicate that *5HT2b* in a small subset, probably a single pair, of dFB neurons is necessary for the regulation of sleep homeostasis.

Discussion {#s3}
==========

Our results indicate that the 5HT2b receptor is required in one pair of dFB neurons to regulate sleep homeostasis. Our finding of the differential roles of the receptors in promoting sleep and in regulating sleep recovery clearly show that the total amount of sleep and sleep recovery after deprivation may involve different mechanisms. dFB neurons have been shown to be important in sleep ([@bib20]). Our results not only reveal that serotonergic signaling is crucial but also show that the expression of *5HT2b* in a very small subset of dFB neurons is necessary and sufficient and explain the function of the 5HT2b receptor in sleep regulation. The intersectional strategy has shown 2--4 pairs of neurons that are positive for both 5HT2b and 23E10 but only one pair is shown with the non-intersectional strategy. This could be due to the possibility that the intersectional strategy may involve protein expression at an immature developmental stage, whereas the drivers in the non-intersectional strategy directly showed expression in mature neurons. Other brain regions and neurotransmitters have been implicated in sleep regulation. Sleep is also regulated by dopamine and its G-protein-coupled receptor *DopR* in PPL1 and PPM3 clusters ([@bib48]; [@bib90]). It will be interesting to investigate whether and how dopaminergic and serotonergic systems interact to regulate sleep or sleep homeostasis in drosophila. Two separate excitatory synaptic microcircuits oppositely regulate sleep, and the activity of the sleep-promoting microcircuit in the MB is increased after sleep deprivation ([@bib5]; [@bib85]). A subset of EB neurons encode sleep drive by modulating calcium level and synaptic strength ([@bib50]). It will also be interesting to investigate how different regions in the brain work with each other to regulate sleep.

Mutants exhibited normal circadian periods, but we could not rule out other circadian rhythm defects, such as circadian entrainment. It has been reported that *5HT1a* mutants have slight reduced recovery sleep after 6 hr of sleep deprivation ([@bib99]). In this study, however, we found normal sleep rebound after 12-hr sleep deprivation. One possibility that might explain this discrepancy is that we used different *5HT1a* mutants. In the sleep-recovery experiment, we observed no significant difference between wt flies fed with mock or 5HTP, which indicated that wt 5-HT level was probably saturated for sleep recovery. Although the daytime sleep of mutant flies with 5HTP rescue was higher than that of the wt, there was still room for increase if the recovery ability of the flies is restored. Therefore sleep rebound could be dissociated from the baseline sleep. In mammals, the role of 5-HT in sleep is controversial. Early results from lesion and neuropharmacological studies had implicated 5-HT in the initiation and maintenance of slow wave sleep (SWS) ([@bib38]) , but other reports challenged the serotonergic hypothesis of sleep promotion ([@bib56]). Recent papers claimed that the observed changes in sleep were indirect as resulted from 5-HT involvement in thermoregulation when all serotonergic neurons were genetically deleted in mice ([@bib10]; [@bib34]). Our unpublished data revealed that sleep was decreased in Tph2^--/^-- mice, in which serotonin could not be synthesized in the brain but with normal thermoregulation (Yan HM and YR). However, it has not been studied whether 5-HT is important for sleep rebound after deprivation in mammals.

The ventrolateral preoptic nucleus (VLPO) is thought to be important for sleep control in mammals. Its activity correlates with the sleep/wake cycle ([@bib12]; [@bib26]; [@bib39]; [@bib51]; [@bib81]; [@bib80]). Interestingly, both the mammalian VLPO and the drosophila dFB are sensitive to isoflurane, a general hypnotic anesthetic, with the dFB known to show higher sensitivity to isoflurane after sleep deprivation ([@bib41]; [@bib52]; [@bib57]; [@bib60]). Both the VLPO and the dFB increase their firing rates in response to sleep deprivation ([@bib3]; [@bib20]). Furthermore, the VLPO contains a subset of sleep-promoting neurons that are excitable by 5-HT, and another subset of neurons that are inhibitable by 5-HT ([@bib24]). It is not known which 5-HT receptors in the VLPO mediated these responses. In mice, 5HT2A and 5HT2C receptors are homologs of the drosophila 5HT2b receptor. Like drosophila *5HT2b* mutants, 5HT2C receptor knock-out mice had more wakefulness and abnormalities in rapid eye movement (REM) sleep ([@bib23]). *5HT2A* mutant mice exhibited increased wakefulness and reduced non-rapid eye movement (NREM) sleep ([@bib69]). It will be interesting to examine the VLPO distributions of 5HT2C and 5HT2A receptors in mammals and to investigate their roles in sleep homeostasis.

Our results provided genetic and neural illustrations of how serotonin affects sleep regulation. Further studies are required to elucidate the neurochemistry and physiology of dFB neurons in sleep regulation and to refine the downstream effectors of dFB neurons. It will be of great interest to determine whether the serotonin in dFB that regulates sleep also influences memory formation.

Materials and methods {#s4}
=====================

Drosophila stocks and culture {#s4-1}
-----------------------------

Flies were reared at 25°C and 60% humidity and were kept in a 12-hr light-12-hr dark cycle (or in constant darkness when specified). For thermogenetic activation of neurons, flies were raised and loaded into the visual-recording system at 22°C. Temperature was changed to 28°C when neural activation to place. Flies were backcrossed into a Canton S for at least five generations. UAS-Hid, Dilp2-Gal4, Pdf-Gal4 and MB247-Gal4 were generously provided by Aike Guo (Institute of Biophysics, CAS). Tub \> Gal80 \> was provided by Jing Wang (UCSD). UAS-StingerGFP and LexAop-tdTomato were gifts from Barry Dickson (Janelia Research Campus, HHMI). UAS-TrpA1 was provided by Paul Garrity (Brandeis University). UAS-mCD8GFP, UAS-StingerGFP, UAS-DscamGFP, UAS-sytGFP, UAS-DenMark, UAS-NachBach, UAS-FRT-stop-FRT-mCD8GFP, 23E10-Gal4, 23E10-LexA, 69F08-Gal4, 18H11-Gal4, LexAop-Gal80, TH-Gal4 and LexAop-Flp were obtained from the Bloomington Stock Center. UAS-5HT2b-RNAi (KK102356) was obtained from the Vienna Drosophila Resource Center (VDRC). [Table 1](#table1){ref-type="table"} contains the complete genotypes used in the figures.
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###### Complete genotypes used in the figures.

This table contains the genotypes of flies used in imaging and behavioral analysis.

  [Figure 1](#fig1){ref-type="fig"}                           
  ----------------------------------------------------------- -------------------------------------------------------------------
  E--J                                                        Iso-CS
                                                              w+;5HT1a^Gal4^;+
                                                              w+;5HT1b^Gal4^;+
                                                              w+;+;5HT2a^Gal4^
                                                              w+;+;5HT2b^Gal4^
                                                              w+;+;5HT7^Gal4^
                                                              w+;+;Trh^01^
                                                              w+;+;Trh^GKO^
  [Figure 2](#fig2){ref-type="fig"}                           
  A,B                                                         Iso-CS
                                                              w+;5HT1a^Gal4^;+
                                                              w+;5HT1b^Gal4^;+
                                                              w+;+;5HT2a^Gal4^
                                                              w+;+;5HT2b^Gal4^
                                                              w+;+;5HT7^Gal4^
                                                              w+;+;Trh^01^
                                                              w+;+;Trh^GKO^
  C,D                                                         Iso-CS(Mock)
                                                              Iso-CS(5HTP)
                                                              w+;+;Trh^01^(Mock)
                                                              w+;+;Trh^01^(5HTP)
                                                              w+;+;Trh^GKO^(Mock)
                                                              w+;+;Trh^GKO^(5HTP)
  E, H--J                                                     w−;+;UAS-TrpA1/+
                                                              w-−;+;TH-Gal4/+
                                                              w−;+;UAS-TrpA1/TH-Gal4
  F, H--J                                                     w−;+;UAS-TrpA1,Trh^01^/Trh^01^
                                                              w−;+;TH-Gal4,Trh^01^/Trh^01^
                                                              w−;+;UAS-TrpA1,Trh^01^/TH-Gal4,Trh^01^
  G, H--J                                                     w−;+;UAS-TrpA1,5HT2b^attp^/5HT2b^attp^
                                                              w−;+;TH-Gal4,5HT2b^attp^/5HT2b^attp^
                                                              w−;+;UAS-TrpA1,5HT2b^attp^/TH-Gal4,5HT2b^attp^
  [Figure 3](#fig3){ref-type="fig"}                           
  A                                                           w−;UAS-mCD8GFP/+;Trh::Gal4/+
  B                                                           w−;UAS-stingerGFP/+;Trh::Gal4/+
  C                                                           w−;UAS-DscamGFP/+;Trh::Gal4/+
  D                                                           w−;UAS-sytGFP/+;Trh::Gal4/+
  E                                                           w−;UAS-mCD8GFP/+;5HT2b::Gal4/+
  F                                                           w−;UAS-stingerGFP/+;5HT2b::Gal4/+
  G                                                           w−;UAS-DscamGFP/+;5HT2b::Gal4/+
  H                                                           w−;UAS-sytGFP/+;5HT2b::Gal4/+
  [Figure 4](#fig4){ref-type="fig"}                           
  A                                                           w−;+;UAS-5HT2b-RNAi/+
                                                              w−;+;5HT2b::Gal4/+
                                                              w−;+;5HT2b::Gal4/UAS-5HT2b-RNAi
                                                              w−;+;MB247-Gal4/+
                                                              w−;+;MB247-Gal4/UAS-5HT2b-RNAi
                                                              w−;+;R69F08-Gal4/+
                                                              w−;+;R69F08-Gal4/UAS-5HT2b-RNAi
                                                              w−;+;pdf-Gal4/+
                                                              w−;+;pdf-Gal4/UAS-5HT2b-RNAi
                                                              w−;+;dilp2-Gal4/+
                                                              w−;+;dilp2-Gal4/UAS-5HT2b-RNAi
                                                              w−;+;R18H11-Gal4/+
                                                              w−;+;R18H11-Gal4/UAS-5HT2b-RNAi
                                                              w−;+;R23E10-Gal4/+
                                                              w−;+;R23E10-Gal4/UAS-5HT2b-RNAi
  B                                                           w−;UAS-mCD8GFP/+;23E10-Gal4/+
  C                                                           w−;UAS-DenMark,UAS-sytGFP/+;23E10-Gal4/+
  D,E                                                         w−;UAS-FRT-stop-FRT-mCD8GFP/+;
  5HT2b-LexA,23E10-Gal4/LexAop-Flp                            
  F--H                                                        w−;UAS-stingerGFP,LexAop-TdTomato/+;5HT2b-LexA,23E10-Gal4/+
  I--K                                                        w−;+;5HT2b^sfGFP^/+
  L--N                                                        w−;UAS-5HT2b^sfGFP^/+;23E10-Gal4/+
  [Figure 5](#fig5){ref-type="fig"}                           
  B--C(I)                                                     w−; +;5HT2b-LexA,23E10-Gal4/+
  B--C (II)                                                   w−;Tub \> Gal80\>/+;LexAop-Flp/+
  B--C (III)                                                  w−;UAS-Nachbach/+;+
  B--C (IV)                                                   w−;UAS-Hid/+;+
  B--C (V)                                                    w−;Tub \> Gal80\>,UAS-Nachbach/+;5HT2b-LexA,23E10-Gal4/LexAop-Flp
  B--C (VI)                                                   w−;Tub \> Gal80\>,UAS-Hid/+;5HT2b-LexA,23E10-Gal4/LexAop-Flp
  E--F(I)                                                     w−;+;5HT2b-LexA,23E10-Gal4/+
  E--F(II)                                                    w−;+;Tub \> Gal80\>/+;Lexop-Flp/+
  E--F(III)                                                   w−;UAS-Hid/+;+
  E--F(IV)                                                    w−;Tub \> Gal80\>,UAS-Hid/+;5HT2b-LexA,23E10-Gal4/LexAop-Flp
  [Figure 6](#fig6){ref-type="fig"}                           
  B--E(I)                                                     w+;+;+
  B--E(II)                                                    w−;+;5HT2bGKO/5HT2battp
  B--E(III)                                                   w−;UAS-5HT2b/+;5HT2b^GKO^/5HT2b^attp^
  B--E(IV)                                                    w−;UAS-5HT2b/+;5HT2b^attp^/5HT2b^attp^
  B--E(V)                                                     w−;+;23E10-Gal4,5HT2b^attp^/5HT2b^attp^
  B--E(VI)                                                    w−;UAS-5HT2b/+;23E10-Gal4,5HT2b^attp^/5HT2b^attp^
  G--J(I)                                                     w−;23E10-LexA/+;5HT2b^GKO^/5HT2b^attp^
  G--J(II)                                                    w−;UAS-5HT2b/+;5HT2b^GKO^,LexAop-Gal80/5HT2b^attp^
  G--J(III)                                                   w−;UAS-5HT2b/23E10-LexA;5HT2b^GKO^,LexAop-Gal80/5HT2b^attp^
  L--O(I)                                                     w−;+;23E10-Gal4/+
  L--O(II)                                                    w−;UAS-5HT2b-RNAi/+;23E10-Gal4/+
  L--O(III)                                                   w−;23E10-LexA/+;5HT2b::Gal4/+
  L--O(IV)                                                    w−;LexAop-Gal80/+;UAS-5HT2b-RNAi/+
  L--O(V)                                                     w−;LexAop-Gal80/23E10-LexA;5HT2b::Gal4/UAS-5HT2b-RNAi
  [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}   
  A                                                           w+;+;+
  B                                                           w-;+;Trh::Gal4
  C                                                           w+;+;Trh^01^
  D                                                           w+;+;Trh^GKO^
  E                                                           w+;+;Trh^01^
  F                                                           w+;+;Trh^GKO^
  G                                                           w+;+;Trh^01^
  H                                                           w+;+;Trh^GKO^
  I-J                                                         isoCS
                                                              w+;+;Trh^01^
  [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}   
  A--F                                                        Iso-CS
                                                              w+;5HT1a^Gal4^;+
                                                              w+;5HT1b^Gal4^;+
                                                              w+;+;5HT2a^Gal4^
                                                              w+;+;5HT2b^Gal4^
                                                              w+;+;5HT7^Gal4^
                                                              w+;+;Trh^01^
                                                              w+;+;Trh^GKO^
  [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}   
  A--F                                                        Iso-CS
                                                              w+;5HT1a^Gal4^;+
                                                              w+;5HT1b^Gal4^;+
                                                              w+;+;5HT2a^Gal4^
                                                              w+;+;5HT2b^Gal4^
                                                              w+;+;5HT7^Gal4^
                                                              w+;+;Trh^01^
                                                              w+;+;Trh^GKO^
  [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}   
  A--B                                                        Iso-CS
                                                              w+;5HT1a^Gal4^;+
                                                              w+;5HT1b^Gal4^;+
                                                              w+;+;5HT2a^Gal4^
                                                              w+;+;5HT2b^Gal4^
                                                              w+;+;5HT7^Gal4^
                                                              w+;+;Trh^GKO^
  [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}   
  A--B                                                        Iso-CS
                                                              w+;5HT1a^Gal4^;+
                                                              w+;5HT1b^Gal4^;+
                                                              w+;+;5HT2a^Gal4^
                                                              w+;+;5HT2b^Gal4^
                                                              w+;+;5HT7^Gal4^
                                                              w+;+;Trh^01^
  [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}   
  B                                                           Iso-CS
                                                              w+;+;5HT2b^Gal4^
                                                              w+;+;Trh^01^
  C                                                           Iso-CS
                                                              w+;5HT1a^Gal4^;+
                                                              w+;5HT1b^Gal4^;+
                                                              w+;+;5HT2a^Gal4^
                                                              w+;+;5HT2b^Gal4^
                                                              w+;+;5HT7^Gal4^
                                                              w+;+;Trh^01^
                                                              w+;+;Trh^GKO^
  [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}   
  A                                                           w+;UAS-mCD8GFP/+;Trh::Gal4/+
  B                                                           w+;UAS-mCD8GFP/+;Trh^GKO^/+
  C                                                           w+;UAS-mCD8GFP/+;5HT2b::Gal4/+
  D                                                           w+;UAS-mCD8GFP/+;5HT2b^GKO^/+
  E                                                           w+;UAS-mCD8GFP/+;5HT2b-LexA/+
  F                                                           w−;UAS-mCD8GFP/+;Trh::Gal4/+
  G                                                           w−;UAS-stingerGFP/+;Trh::Gal4/+
  H                                                           w−;UAS-DscamGFP/+;Trh::Gal4/+
  I                                                           w−;UAS-sytGFP/+;Trh::Gal4/+
  J                                                           w−;UAS-mCD8GFP/+;5HT2b::Gal4/+
  K                                                           w−;UAS-stingerGFP/+;5HT2b::Gal4/+
  L                                                           w−;UAS-DscamGFP/+;5HT2b::Gal4/+
  M                                                           w−;UAS-sytGFP/+;5HT2b::Gal4/+
  [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}   
  A                                                           w−;+;5HT2b::Gal4/+
                                                              w−;+;UAS-5HT2b-RNAi
                                                              w−;+;5HT2b::Gal4/UAS-5HT2b-RNAi
  B                                                           w−;UAS \> Stop \> mCD8GFP/+;Lexop-Flp,5HT2b-LexA/MB247-Gal4
                                                              w−;UAS \> Stop \> mCD8GFP/+;Lexop-Flp,5HT2b-LexA/R69F08-Gal4
                                                              w−;UAS \> Stop \> mCD8GFP/+;Lexop-Flp,5HT2b-LexA/Pdf-Gal4
                                                              w−;UAS \> Stop \> mCD8GFP/+;Lexop-Flp,5HT2b-LexA/Dilp2-Gal4
                                                              w−;UAS \> Stop \> mCD8GFP/+;Lexop-Flp,5HT2b-LexA/R18H11-Gal4
                                                              w−;UAS \> Stop \> mCD8GFP/+;Lexop-Flp,5HT2b-LexA/R23E10-Gal4
  [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}   
  A--B                                                        w−;23E10-Gal4/+;+
                                                              w−;UAS-Nachbach/+;+
                                                              w−;23E10-Gal4/UAS-Nachbach;+
  C                                                           w−;23E10-Gal4/UAS-stingerGFP;+
  D                                                           w−;23E10-Gal4/UAS-Hid,UAS-stingerGFP;+
  E--H                                                        w−;23E10-Gal4/+;+
                                                              w−;UAS-Hid/+;+
                                                              w−;23E10-Gal4/UAS-Hid;+
  [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}   
  B                                                           w−;Tub \> Gal80\>,UAS-mCD8GFP/+;5HT2b-LexA,23E10-Gal4/LexAop-Flp
  C                                                           w−;Tub \> Gal80\>,UAS-mCD8GFP/+;23E10-Gal4/+
  E                                                           w−;UAS-stingerGFP,LexAop-tdTom/23E10-LexA;5HT2b^GKO^/+
  F                                                           w−;UAS-stingerGFP,LexAop-tdTom/23E10-LexA;

5HT2b^GKO^,LexAop-Gal80/+.

Pharmacological treatment of flies with 5-HTP {#s4-2}
---------------------------------------------

5-HTP was obtained from Sigma. Wt or *Trh* mutant flies were raised with normal food during the larval stage and immediately transfered to 5HTP food (5% sucrose, 2% agar and 2 mg/ml 5HTP) after eclosion. For immunostaining analysis, after three days of feeding with 5HTP-containing food, flies were dissected for immunohistochemistry. For behavioral analysis, flies were fed with 5HTP food after eclosion (usually 3--5 days), then transferred to glass tubes with 5HTP food for sleep analysis.

Construction of transgenic, knockout and knockin lines of drosophila {#s4-3}
--------------------------------------------------------------------

The UAS-5HT2b DNA construct was generated by subcloning *5HT2b* cDNA into the pACU2 vector, with the *5HT2b* cDNA from the Vosshall lab at Rockefeller University and the pACU2 vector from the Jan Lab at UCSF ([@bib25]; [@bib32]). Superfoder GFP cDNA was subcloned from the Addgene plasmid (No.60904).

The end-out method was used to generate mutant lines ([@bib35]). Gal4 was introduced to replace the gene by homologous recombination. In each of the targeting constructs, the entire first exon with the first ATG codon of the gene (or the entire gene) was deleted. At least the first transmembrane domains of the seven transmembrane domains in a receptor were also deleted to ensure null mutants. The 5' homologous arms (\~5 KB) and the 3' homologous arm (\~3 KB) were inserted into pGX2 vectors by homologous recombination repair. We named the receptor mutants using Strategy I as 5HT1a^Gal4^, 5HT1b^Gal4^, 5HT2a^Gal4^, 5HT2b^Gal4^ and 5HT7^Gal4^. We also introduced loxp and attp sites along with Gal4, which enabled us to flip out the introduced sequence when crossing with a cre strain, leaving a functional attp site in the gene targeted region ([Figure 1B](#fig1){ref-type="fig"}). We named the *5HT2b* mutant with introduced sequence flipped out 5HT2b^attp^ ([Figure 2G--H](#fig2){ref-type="fig"} and [Figure 6A--J](#fig6){ref-type="fig"}).

The Crispr/Cas9 system was used to generate *Trh* indel mutant flies. The gRNA and Cas9 mRNA were designed and generated as described previously ([@bib97]). The gRNA targeted the catalytic center of the Trh enzyme. We named the *Trh* indel mutant Trh^01^. PCR analysis and DNA sequencing were used for further confirmation.

Two different gRNAs were used to generate deletion in genome regions of interest. The sgRNA sequence was subcloned into a U6b-sgRNA vector to generate gRNA in fly embryos ([@bib72]). The nos-Cas9 flies were used for injection. The 5' homologous arms (\~2.5 KB) and the 3' homologous arm (\~3 KB) were inserted into a pBSK vector for homologous recombination repair. Arm fragments were amplified from the wt fly genome by Phanta Max DNA polymerase (Vazyme Biotech Co. Ltd.). The Gal4, Flp or LexA effector sequence was introduced between the two homologous arms and 3p3-RFP was used as the fluorescent marker for screening ([@bib94][@bib95]). We named the *Trh* with Gal4 knockin using Strategy II strain Trh^GKO^, and the *Trh* Gal4 knockin using Strategy III strain Trh::Gal4. We named the 5HT2b with Gal4 knockin using Strategy II strain 5HT2b^GKO^, the 5HT2b LexA knockin using Strategy II strain 5HT2b-LexA, and the Gal4 knockin using Strategy III strain 5HT2b::Gal4. PCR analysis and DNA sequencing were used for further confirmation. [Table 2](#table2){ref-type="table"} contains the primers and sgRNAs used.
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###### Primers and sgRNA.

The table contains the primers and sgRNA used in line construction.

  -------------------------------------------------- --------- --------------------------------- ------------------------------------------------
  5HT1a                                              3\' arm   For                               ATGCTA[GCGGCCGC]{.ul}GAGATTCGGA\
                                                                                                 GGGAAAAGAATGTG

                                                               Rev                               TACCAT[GGTACC]{.ul}TTTGTGGATACTCG\
                                                                                                 GTGTGTTTTTTTG

                                                     5\' arm   For                               AAGTCG[ACTAGT]{.ul}AGCCAAAGCCCAAACATAGA

                                                               Rev                               TTCCAT[GGCGCGCC]{.ul}CCAACGAGCCATTTGAGATT

  5HT1b                                              3\' arm   For                               ATGCTA[GCGGCCGC]{.ul}TGGCATAGTTTTTCGCTGTG

                                                               Rev                               TACCAT[GGTACC]{.ul}CTCGCTTGTATATATGTA\
                                                                                                 TATGTATATC

                                                     5\' arm   For                               AAGTCG[ACTAGT]{.ul}CCATATCGCCGACAAAAACT

                                                               Rev                               TTCCAT[GGCGCGCC]{.ul}GTTGGCATTTGTTTGGCTTT

  5HT2a                                              3\' arm   For                               ATGCTA[GCGGCCGC]{.ul}CATGGTCAACATGGGTTCAA

                                                               Rev                               TACCAT[GGTACC]{.ul}TTCATTCTAAAGCTGTGGGGC

                                                     5\' arm   For                               TTCCAT[GGCGCGCC]{.ul}AAACTTGTTGGCCTTGTTGG

                                                               Rev                               TACTGC[AGGCCT]{.ul}GCGCAATTGCTTAACAGACA

  5HT2b                                              3\' arm   For                               ATGCTA[GCGGCCGC]{.ul}GAAATGTTGCCGTGAGTCT

                                                               Rev                               TAGGAT[CCGCGG]{.ul}TCCGCGTTATTATTCCTATTGTG

                                                     5\' arm   For                               AAGTCG[ACTAGT]{.ul}TTCAAAGTCCGGAACAGAGG

                                                               Rev                               TTCCAT[GGCGCGCC]{.ul}AAACTCCATTTTCCGCACAG

  5HT7                                               3\' arm   For                               ATGCTA[GCGGCCGC]{.ul}AAGGACAAAGGCGACACATC

                                                               Rev                               TACCAT[GGTACC]{.ul}CAGCAGTCTTTCAATGGTGG

                                                     5\' arm   For                               AAGTCG[ACTAGT]{.ul}CCCTAGGTTTCCGGAAGAAG

                                                               Rev                               TTCCAT[GGCGCGCC]{.ul}ACACATATCCCCGTCCACAT

  Primers and sgRNAs used in strategies II and III                                               

  Trh^GKO^                                                     For                               cgg[GGTACC]{.ul}ATGAACAGTCTTTAGCCACG

                                                     5' arm    Rev                               cgc[ggatccGCGGCCGC]{.ul} TCACCCTGCGTAACCAGGTG

                                                     3' arm    For                               cgc[ggatccGGCGCGCC]{.ul} CACAACAGCCTGAATGTGAG

                                                               Rev                               tcc[ccgcgg]{.ul}TGCTACATTAAATCCTCCCA

                                                     gRNA                                        GAATGTGCTCATGTACGGCT[CGG]{.ul}

                                                                                                 GAGAGCATCCAACGGCCATT[TGG]{.ul}

  Trh::Gal4                                          5' arm    For                               cgg[ggtacc]{.ul}AAGTCTCGGCAGAAACGCCTC

                                                               Rev                               taac[accggtgcggccgc]{.ul}ATCTCCCTCCGCCGTAGAGTT

                                                     3' arm    For                               taac[accggtggcgcgcc]{.ul}TTCTCGGGACCACAGAGCAGT

                                                               Rev                               tcc[ccgcgg]{.ul}AATTTCGGCAGGACACCTCTG

                                                     gRNA                                        GGACAGCAATGAAACCTTAA[GGG]{.ul}

                                                                                                 ACAGAGCAGTATAATTCACT[TGG]{.ul}

  5HT2b^GKO^/LexA                                    5' arm                                      cggGGTACCATTTGTGCCGTGTCCTGTAT

                                                                                                 cgc[ggatccGCGGCCGC]{.ul}CTGCAGCCGGCGCTCCCAGG

                                                     3' arm                                      cgc[ggatccGGCGCGCC]{.ul}TGCGGCTAATCTTAGTTGGA

                                                                                                 tcc[ccgcgg]{.ul}GCATGGGTCTTGTTTCGTTT

                                                     gRNA                                        GGGCATCCTTACGCTGGTGAA[AGG]{.ul}

                                                                                                 GGATAGAAAAATGGAATCGC[TGG]{.ul}

  5HT2b::Gal4                                        5' arm    For                               cgg[ggtacc]{.ul}CGAGCTGACCACAAAGCGTGC

                                                               Rev                               taac[accggtgcggccgc]{.ul}TCTGCTCGGTCGCCAGGCACT

                                                     3' arm    For                               taac[accggtggcgcgcc]{.ul}AGGATTCCACTGCTCCGGTGC

                                                               Rev                               tcc[ccgcgg]{.ul}AGTTTCGCTCTGTGGAAACCG

                                                     gRNA                                        TAACAGACGCCCGTTAAACC[GGG]{.ul}

                                                                                                 ATCCACACTGGCGCACTTGT [GGG]{.ul}

  Primers in qRT-PCR                                                                             

  5HT2b For                                                    CCAACTACTTCCTTATGTCG              

                                                     Rev       GATAAATATCTGTCCACGGA              

  Act42a                                             For       CTCCTACATATTTCCATAAAAGATCCAA      

                                                     Rev       GCCGACAATAGAAGGAAAAACTG           

  gRNA for Trh^01^                                             GGAGATTGGCCTTGCATCTTT[GGG]{.ul}   
  -------------------------------------------------- --------- --------------------------------- ------------------------------------------------

qRT-PCR {#s4-4}
-------

For each sample, 20 flies were ground on ice. RNA and cDNA were generated with the PrimerScript RT Master Mix (Takara). qRT--PCR was performed using TransStart Green qPCR SuperMix (Transgen Biotech) and the 96-well Applied Biosystems 7900HT Real-Time PCR System.

Sleep analysis {#s4-5}
--------------

Female or male flies aged 4--6 days were transferred into monitor tubes (5 mm × 65 mm) containing normal food. 48 flies were usually used in each group in our experiments. Female flies were used for sleep analysis if not specifically mentioned. Light was on from 9:00am to 9:00pm. Locomotor activity was monitored in the LD cycle using a video system ([@bib27]; [@bib96]; [@bib101]). Infrared LEDs were used for constant illumination for video recording. Images were acquired every second (sec) and processed by Visual C++ to determine the location of the flies. Sleep was defined as no detectable movement for 5 min or longer. Sleep parameters were calculated using Matlab (MathWorks, Natick, MA). Sleep duration, sleep bout duration, sleep latency and wake activity were analyzed for each 12-hr period of LD and DD for each condition. Female flies were sleep deprived by the mechanical method using a steering engine, which randomly shook for 20 s in 3 min ([@bib79]). Sleep deprivation efficiency was recorded by a DAM system. Sleep loss was defined as total sleep duration last night. Individual sleep rebound was quantified hourly for 24 hr by dividing the cumulative amount of sleep regained by the sleep duration last night. Each experiment was repeated twice or three times.

Circadian analysis {#s4-6}
------------------

Male flies aged 3--6 days were housed individually in 65 mm glass tubes containing normal food. Locomotor activity was measured in TriKinetics DAM systems for 12 days in constant darkness. Periodogram analysis was completed with the Actogram J plugin ([@bib76]). Period length was determined by periodogram analysis.

Confocal microscopy {#s4-7}
-------------------

Adult female flies of 5--10 days of age were collected and their CNS dissected in phosphate buffered saline (PBS). The brains were subject to 4% paraformaldehyde (wt/vol) fixation in the PBS for 2--4 hr and washed three times with the wash buffer (3% NaCl in 0.1% PBT) for 10 min at room temperature. Samples were transferred to 10% normal goat serum (vol/vol, diluted in 1% PBT) for overnight blocking at room temperature and incubated with antibodies (diluted in 10% normal goat serum and 0.1% PBT) at 4°C overnight. After washing samples three times for 15 min with wash buffer at room temperature and incubating samples with secondary antibody (1:500) at 4°C overnight, we mounted the samples with FocusClear (CelExplorer Labs CO) and imaged them on a Zeiss LSM710 confocal microscope. Images were processed using Imaris (Bitplane AG, Zurich, Switzerland, 640 RRID: [SCR_007370](https://scicrunch.org/resolver/SCR_007370)). The following antibodies were used, chicken anti-GFP (1:1000; Abcam Cat\# 13970, RRID:[AB_300798](https://scicrunch.org/resolver/AB_300798)), rabbit anti-RFP (1:2000; Clontech Cat\# 632496, RRID: [AB_10013483](https://scicrunch.org/resolver/AB_10013483)), rabbit anti-5-HT (1:2000; Immunostar Cat\# 20080, RRID:[AB_572263](https://scicrunch.org/resolver/AB_572263)), mouse anti-nc82 (1:50; DSHB Cat\# 2314866, RRID: [AB_2314866](https://scicrunch.org/resolver/AB_2314866)), rat-anti Myc (1:500, Transgen). Secondary antibodies were AlexaFluor488 anti-rabbit (Life technologies Cat\# A11008, RRID:[AB_10563748](https://scicrunch.org/resolver/AB_10563748)), AlexaFluor488 anti-chicken (Life technologies Cat\# A11039, RRID:[AB_2534096](https://scicrunch.org/resolver/AB_2534096)), AlexaFluor546 anti-rabbit (Life technologies Cat\# A11035, RRID:[AB_2534093](https://scicrunch.org/resolver/AB_2534093)), and AlexaFluor633 anti-mouse (Life technologies Cat\# A21052, RRID: [AB_141459](https://scicrunch.org/resolver/AB_141459)).

Statistics {#s4-8}
----------

Pairwise comparisons were evaluated by Student's t test. ANOVA with Holm-Sidak corrections for multiple comparisons was used to test hypotheses involving multiple groups. Statistical analyses were performed with Prism 5 (GraphPad).
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Decision letter
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Reviewing Editor

Howard Hughes Medical Institute, University of Pennsylvania

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Sleep Homeostasis Regulated by 5HT2b Receptor in a Single Pair of Neurons in the Dorsal Fan-Shaped Body of *Drosophila*\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Kazuhiko Kume (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. Given the nature of the essential revisions described below, it may be best for you to respond with a plan and a timetable for the completion of this work. We will share this with the board member and reviewers and get back to you with recommendations.

Overall, the reviewers found your manuscript to provide an important and comprehensive analysis of the role of serotonin and different serotonin receptors in *Drosophila* sleep. In particular, localization of 5-HT2B effects on sleep to a pair of neurons in the fan-shaped body (FSB) would constitute a significant advance. However, the reviewers felt that the manuscript fell short of mapping 5HT2B function to the two FSB neurons. Necessity and sufficiency of 5HT2B in these neurons should be addressed through RNAi and rescue analysis respectively. The reviewers also recommend more comprehensive analysis of sleep rebound. In particular, they suggest inclusion of other methods of deprivation, such as activation of arousal promoting monoaminergic neurons, and also a weaker mechanical deprivation protocol (to exclude effects of serotonin on mechanical sensitivity). For all sleep homeostasis experiments, rebound measurements should be based on the actual amount of sleep lost by each individual fly, and post-rebound data should be evaluated to ensure a return to normal sleep levels.

For the broad readership of *eLife*, we also recommend that you include a schematic to depict the different brain regions assayed.

A number of clarifications and corrections are required:

Was 5HT2BGal4\>5HT2B RNAi validated by RT-PCR or by testing whether RNAi reduces 5HT2BsfGFP signal?

Major changes in baseline are apparent in the paper and are somewhat of a concern, with 600 min in [Figure 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, but much lower elsewhere (e.g. 400 min in [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}/1F). In addition, between Figure 1EF and [Figure 1---figure supplement 2I](#fig1s2){ref-type="fig"}J, the daytime sleep phenotype of Trh01 appears different. Between [Figure 2C and 2E](#fig2){ref-type="fig"}, the rebound pattern appears very different in the same wild type flies. In 2C, the rebound mainly occurred during the daytime while in 2E, rebound occurred at night. What accounts for this difference?

What was the time course of 5HTP treatment for experiments shown in [Figure 2E-F](#fig2){ref-type="fig"}? The legend describes \"Three day feeding of 2 mg/ml 5HTp\" -- did administration begin at the start of the baseline day and extend through the deprivation and recovery days? Or did it include 3 days prior to the baseline day? If the effects of 5HT on baseline sleep (Yuan et al., Curr Biol 16: 1051; 2006) were ramping up during the baseline day used to calculate sleep rebound, it would be impossible to dissociate the effects of 5HTP on baseline sleep and sleep rebound.

Also, do [Figure 2E](#fig2){ref-type="fig"}/2F analyze the same populations of animals? The data look to be the same for most genotypes, but data for Trh01+5HTP appear to be different (\<30% sleep recovery in [Figure 2E](#fig2){ref-type="fig"} vs. \>40% sleep recovery in [Figure 2F](#fig2){ref-type="fig"}). If [Figure 2C](#fig2){ref-type="fig"} is from a single experiment, this should be stated along with population sizes (n).

Subsection "5-HT Regulation of Sleep Recovery After Deprivation Through its 2b Receptor": [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} should include the 24 hr time profile data after sleep deprivation since the quantification was performed using 24 hr data in [Figure 2](#fig2){ref-type="fig"} and others.

Necessary genetic controls are missing for [Figure 5B-C](#fig5){ref-type="fig"} (Undriven UAS-Nachbach and UAS-Hid), 5E-F (Undriven LexAop-Flp, Tub\>Gal80\> & UAS-Hid) and 6B-E (5HT2b mutants with gal4 drivers but no UAS rescue).

[Figure 3A](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"} appear to be nearly duplicate images (perhaps adjacent Z-sections). The authors should state this clearly so that readers do not get the impression that data are duplicated.

Subsection "Manipulation of 5HT2b and dFB intersectional neurons regulates sleep duration and homeostasis", last paragraph: What was the efficiency of FLP-FRT recombination in the intersectional experiments in [Figure 5](#fig5){ref-type="fig"}?

Subsection "Manipulation of 5HT2b and dFB intersectional neurons regulates sleep duration and homeostasis", last paragraph: The description of either [Figure 5D](#fig5){ref-type="fig"} or 5E is wrong. The control genotype III shows impaired sleep rebound.

Rescue manipulations in [Figure 6C](#fig6){ref-type="fig"} should probably have a wild-type (no transgene control), as the effects of overexpressing 5HT2B might not be apparent. Finally, some genotypes in [Figure 6](#fig6){ref-type="fig"} are not fully clear. For animals positive for both \"5HT2B mutant\" and \"5HT2B-GKO (genotype III), are these heterozygotes carrying two modified alleles at the 5HT2B locus?

Earlier work is not correctly cited in various parts of the manuscript (e.g. Becnel et al. 2011, Dierick et al. 2007 are cited as showing 5HT1a mutant flies have altered sleep, but these papers do not report these findings). In addition, the authors should discuss prior work pertinent to their study. For instance, the section on 5HTP feeding should refer to similar experiments done by Yuan et al. (2006) and discuss the possibility that increased sleep in the mutant background results from gain-of-function effects. In addition, findings with 5HT receptor and Trh GAL4 lines should be compared with those if earlier studies (Gnerer et al., 2015; Alekseyenko et al., 2010).

The design and structure of alleles is not adequately described. Primer sequences, deletion junctions, et cetera should be described to enable readers to assess the nature of these alleles and validate them independently.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Sleep Homeostasis Regulated by 5HT2b Receptor in a Single Pair of Neurons in the Dorsal Fan-Shaped Body of *Drosophila* \" for further consideration at *eLife*. Your revised article has been re-evaluated by a Senior Editor, a Reviewing Editor, and three reviewers.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

1\) Genetic controls that were requested in the previous decision letter were not included:

\"Necessary genetic controls are missing for [Figure 5B-C](#fig5){ref-type="fig"} (Undriven UAS-Nachbach and UAS-Hid), 5E-F (Undriven LexAop-Flp, Tub\>Gal80\> & UAS-Hid) & 6B-E (5HT2b mutants with gal4 drivers but no UAS rescue).\"

Undriven UAS-Nachbac/+ and UAS-Hid/+ controls are required for proper interpretation of 5B-C. Data for these lines are included in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} but baseline sleep levels in the other controls between these panels do not appear to be consistent. If the undriven UAS controls from [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} are directly compared to data in [Figure 5C](#fig5){ref-type="fig"}, it is not clear that genotype IV (the expression of Hid in dFB neurons expressing 5HT2b) has a significant decrease in daytime or whole day sleep from UAS-Hid controls or that the night-time sleep in genotype III (expression of NachBac in dFB neurons expressing 5HT2b) is higher than the UAS-Nachbac controls in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}. These results require proper genetic controls to support the author\'s interpretations.

Additionally, 23E10-GAL4 in a 5HT2b mutant background (with no UAS-5HT2b) is needed for [Figure 6B-C](#fig6){ref-type="fig"}.

Rescue manipulations in [Figure 6C](#fig6){ref-type="fig"} should probably have a wild-type (no transgene control), as the effects of overexpressing 5HT2B might not be apparent. Finally, some genotypes in [Figure 6](#fig6){ref-type="fig"} are not fully clear. For animals positive for both \"5HT2B mutant\" and \"5HT2B-GKO (genotype III)\", are these heterozygotes carrying two modified alleles at the 5HT2B locus?

No transgene control or overexpression genotypes have been included.

2\) The interpretation of [Figure 4L-N](#fig4){ref-type="fig"} is not clear. These panels show that driving expression of 5HT2b::sfGFP in the dFB labels dFB neurons with GFP. If the authors want to show subcellular localization of 5HT2b in dFB neurons, the best strategy would be imaging 5HT2b::sfGFP protein-trap signal (see [Figure 4I-K](#fig4){ref-type="fig"}) in flies that also contain R23E10-GAL4;UAS-RFP. That combination would permit clear colocalization with endogenous 5HT2b and dFB axons vs dendrites. Otherwise the authors should refrain from commenting on the subcellular location.

3\) The manuscript and title state that 5HT2b functions in a \"single pair of neurons\", though the intersectional genetic strategies applied to 5HT2b access perhaps two pairs of neurons. The \"single pair of neurons\" is from a different Gal4/LexA overlap experiment ([Figure 4F](#fig4){ref-type="fig"}), which was not used for experiments involving 5HT2b. This is not a sticking point for the conclusion that 5HT2B functions in a subset of 23E10 neurons, but there is no need to overstate the result in the title and paper.

4\) There continue to be a number of errors throughout the revised manuscript (text and figures), including several mentioned in the first round of review. These include mismatched citations to figures in the text (Results), and typographical mistakes. For instance, in the subsection "Genotypes in figures" under [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}, FRT-flanked stop alleles are misspelled as \"Strop\". There are also inconsistencies in the nomenclature.

Note also:

[Figure 1B, C, D](#fig1){ref-type="fig"} are still not legible.

[Figure 1I, J, K](#fig1){ref-type="fig"} are out of order.

[Figure 1---figure supplement 4B](#fig1s4){ref-type="fig"}: in all three panels, legend on x-axis is missing for several genotypes.

For [Figure 2I](#fig2){ref-type="fig"}, the legend can be clarified to indicate that sleep gain is over 24h.

10.7554/eLife.26519.026

Author response

> Overall, the reviewers found your manuscript to provide an important and comprehensive analysis of the role of serotonin and different serotonin receptors in Drosophila sleep. In particular, localization of 5-HT2B effects on sleep to a pair of neurons in the fan-shaped body (FSB) would constitute a significant advance. However, the reviewers felt that the manuscript fell short of mapping 5HT2B function to the two FSB neurons. Necessity and sufficiency of 5HT2B in these neurons should be addressed through RNAi and rescue analysis respectively. The reviewers also recommend more comprehensive analysis of sleep rebound. In particular, they suggest inclusion of other methods of deprivation, such as activation of arousal promoting monoaminergic neurons, and also a weaker mechanical deprivation protocol (to exclude effects of serotonin on mechanical sensitivity). For all sleep homeostasis experiments, rebound measurements should be based on the actual amount of sleep lost by each individual fly, and post-rebound data should be evaluated to ensure a return to normal sleep levels.

Necessity and sufficiency of 5HT2B in one pair of dFB neurons:

We have now used RNAi knockdown of 5HT2b gene in dFB neurons (UAS-5HT2b-RNAi driven by 23E10-Gal4,) to test the necessity of 5HT2b. In addition, we rescued the expression of 5HT2b gene with Gal80 (5HT2b::Gal4, 23E10-LexA, LexAop-Gal80, UAS-5HT2b-RNAi) in dFB neurons in the background of 5HT2b knockdown to test the sufficiency of 5HT2b. New results indicated that dFB gene knockdown strain (23E10-Gal4, UAS-5HT2b-RNAi) showed shortened sleep duration and impaired sleep homeostasis, and that 5HT2b expression in the dFB (5HT2b::Gal4, 23E10-LexA, LexAop-Gal80, UAS-5HT2b-RNAi) was able to rescue the sleep phenotype. We have therefore established the necessity and sufficiency of 5HT2b in the dFB to regulate sleep. The data were presented in [Figure 6K-O](#fig6){ref-type="fig"}.

Analysis of sleep rebound:

We have now used additional methods of deprivation to study sleep homeostasis. We thermogenetically induced sleep loss by expressing transgenic TrpA1 channels (UAS-TrpA1) in dopaminergic neurons (TH-Gal4) which led to sleep deprivation, and we measured the sleep loss, sleep gain and recovery rate in wt, Trh mutant and 5HT2b mutant flies. New results indicated that Trh and 5HT2b mutant flies, after sleep deprivation induced by neural activation, showed abnormal sleep recovery comparing to wt flies ([Figure 2E-J](#fig2){ref-type="fig"}). This method of deprivation, as suggested by the reviewer, is independent of mechanical stimulation, and thus verify the effect of Trh and 5HT2b in sleep rebound after deprivation.

Furthermore, we used weaker mechanical sleep deprivation protocol. Six-hour deprivation mechanical deprivation protocol (ZT18-ZT24) was used to supplement our previous method. Trh and 5HT2b mutants again showed impaired sleep recovery after 6-hour sleep deprivation ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}).

Because it is difficult to trace the fly location during mechanical shakes with the video recording method, we used the DAM system to monitor sleep deprivation. We found that, in wt and mutant flies, sleep deprivation efficiencies were 100% (100% to wt, 100% to 5HT1a-/-, 100% to 5HT1b-/-, 99.3% to 5HT2a-/-, 99.9% to 5HT2b-/-, 100% to 5HT7-/- and 100% to Trh-/-) in [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}. It is reasonable to take the sleep amount of the immediately preceding unperturbed night as sleep loss during the deprivation. The revised manuscript showed the sleep loss and sleep gain in the thermogenetically induced sleep deprivation method.

For wt and mutant flies, we measured sleep recovery for 48 hours immediately after sleep deprivation. We found that sleep recovery took place in the first 24-hour after sleep deprivation, and no significant recovery in the second 24-hour ([Figure 2---figure supplement 3C](#fig2s3){ref-type="fig"}).

> For the broad readership of eLife, we also recommend that you include a schematic to depict the different brain regions assayed.
>
> The revised manuscript included a cartoon in [Figure 4A](#fig4){ref-type="fig"} to depict the different brain regions assayed.
>
> A number of clarifications and corrections are required:
>
> Was 5HT2BGal4\>5HT2B RNAi validated by RT-PCR or by testing whether RNAi reduces 5HT2BsfGFP signal?

RNAi efficiency was validated by qRT-PCR (5HT2b::Gal4 \> UAS-5HT2b-RNAi) ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

> Major changes in baseline are apparent in the paper and are somewhat of a concern, with 600 min in [Figure 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, but much lower elsewhere (e.g. 400 min in [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}/1F).

Genetic background contributes to these differences. In our sleep analysis, to exclude the effects of genetic background on sleep, we out-crossed the flies to *w1118* (isoCS background) for at least 5 generations. However, there were still background differences between flies used in mutant analysis ([Figure 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}) and neural manipulation/neural rescue ([Figure 5](#fig5){ref-type="fig"}, [6](#fig6){ref-type="fig"}). wt flies had normal *white* gene (w+) at X chromosome. For mutant analysis in [Figure 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}, to obtain the same genetic background as much as possible, after outcrossing, we replaced the X chromosome of the KO flies with that of wt. For neural manipulation/neural rescue in [Figure 5](#fig5){ref-type="fig"}, [6](#fig6){ref-type="fig"}, we didn't replace X chromosome after outcrossing, so the X chromosome contains mutated *white* gene (*w1118* or w-). We showed the complete genotypes of flies used in each behavioral experiment as [Table 1](#table1){ref-type="table"} in the revised manuscript.

> In addition, between Figure 1EF and [Figure 1---figure supplement 2I](#fig1s2){ref-type="fig"}J, the daytime sleep phenotype of Trh01 appears different. Between [Figure 2C and 2E](#fig2){ref-type="fig"}, the rebound pattern appears very different in the same wild type flies. In 2C, the rebound mainly occurred during the daytime while in 2E, rebound occurred at night. What accounts for this difference?

Food used in the sleep analysis contributes to these differences. In [Figure 1E, F](#fig1){ref-type="fig"} and [2C](#fig2){ref-type="fig"}, we used normal food (nutrition content shown in the Materials and methods) for sleep analysis, but in the 5HTP rescue experiments, to completely dissolve the 5HTP, we used 5% sucrose and 2% agar as food after eclosion. Previous studies have indicated diet and satiety could affect sleep and sleep homeostasis (e.g. Gatterson et.al. 2010 and Donlea et.al. 2011). We discussed this in the Discussion of the revised manuscript.

> What was the time course of 5HTP treatment for experiments shown in [Figure 2E-F](#fig2){ref-type="fig"}? The legend describes \"Three day feeding of 2 mg/ml 5HTp\" -- did administration begin at the start of the baseline day and extend through the deprivation and recovery days? Or did it include 3 days prior to the baseline day? If the effects of 5HT on baseline sleep (Yuan et al., Curr Biol 16: 1051; 2006) were ramping up during the baseline day used to calculate sleep rebound, it would be impossible to dissociate the effects of 5HTP on baseline sleep and sleep rebound.

We have now described the 5HTP administration in details in the revised manuscript. Wt or Trh mutant flies were raised with normal food during larval stage and immediately transferred to 5HTP food (5% sucrose, 2% agar and 2mg/ml 5HTP) after eclosion. For immunostaining analysis, after three days feeding with 5HTP containing food, flies were dissected for immunohistochemistry. For behavioral analysis, flies were fed with 5HTP food after eclosion (usually 3-5 days), then transferred to glass tubes with 5HTP food for sleep analysis.

In the experiments shown in [Figure 1---figure supplement 2I and J](#fig1s2){ref-type="fig"}, we observed that wt flies fed with 5HTP food increased about 30% sleep time in the whole day which indicated the role of 5HT in sleep promotion and is consistent with a previous study (Yuan et al., Curr Biol, year). In the sleep recovery experiment, we observed no significant difference between wt flies fed with mock and 5HTP, which indicated that 5HT was probably saturation for sleep recovery. Sleep duration is stable during the days we observed. Trh mutant flies fed with 5HTP increased sleep to the level a little higher that wt, and the daytime sleep was about 120 min. Although the daytime sleep of mutant flies with 5HTP is higher than wt, there could still be room for increase if the flies restore the recovery ability. Actually, the daytime sleep in wt flies can increase to \>200 min after sleep deprivation. Recovery can be observed at the sleep-promotion condition and the effects of 5HTP on baseline sleep and sleep rebound can be dissociated.

> Also, do [Figure 2E](#fig2){ref-type="fig"}/2F analyze the same populations of animals? The data look to be the same for most genotypes, but data for Trh01+5HTP appear to be different (\<30% sleep recovery in [Figure 2E](#fig2){ref-type="fig"} vs. \>40% sleep recovery in [Figure 2F](#fig2){ref-type="fig"}). If [Figure 2C](#fig2){ref-type="fig"} is from a single experiment, this should be stated along with population sizes (n).

Figure 2E/2F analyze the same populations of animals. We made mistakes in sample calculation of Trh mutant with 5HTP flies in the original Fig2F. We thank the reviewer for pointing out this. We have now corrected it in the revised manuscript.

> Subsection "5-HT Regulation of Sleep Recovery After Deprivation Through its 2b Receptor": [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} should include the 24 hr time profile data after sleep deprivation since the quantification was performed using 24 hr data in [Figure 2](#fig2){ref-type="fig"} and others.

The revised manuscript now includes the 24-hour time profile data after sleep deprivation.

> Necessary genetic controls are missing for [Figure 5B-C](#fig5){ref-type="fig"} (Undriven UAS-Nachbach and UAS-Hid), 5E-F (Undriven LexAop-Flp, Tub\>Gal80\> & UAS-Hid) and 6B-E (5HT2b mutants with gal4 drivers but no UAS rescue).

In [Figure 5B-C](#fig5){ref-type="fig"}, we have the controls of 5HT2b-LexA, 23E10-Gal4 and LexAop-Flp, Tub\>Gal80\>. We out-crossed each of the strains for 5 generations to reduce the genetic background differences, each of the strains showed stable sleep duration. As a remedy, we analyzed the controls from [Figure 5---figure supplement 1A, B, E, F](#fig5s1){ref-type="fig"}, in which UAS-Nachbach, UAS-Hid were used as controls, the intersectional activation and ablation strain also showed significant sleep increase and decrease, respectively.

In [Figure 5E-F](#fig5){ref-type="fig"}, the earlier version showed the wrong schematic illustration of analysis strategy in [Figure 5D](#fig5){ref-type="fig"}, we have controls of 5HT2b, 23E10 and LexAop-Flp, Tub\>Gal80\>, UAS-Hid. We have corrected the schematic illustration in the revised manuscript.

In [Figure 6B-E](#fig6){ref-type="fig"}, we have both positive (5HT2bGKO \> UAS-5H2b that rescue in all 5HT2b neurons in 5HT2b mutant background, and UAS-5HT2b in wt) and negative controls (UAS-5HT2b in 5HT2b mutant background). The wt flies have *white* (w+) gene in X chromosome, which led to a different genetic background from other strains used in this experiment.

> [Figure 3A](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"} appear to be nearly duplicate images (perhaps adjacent Z-sections). The authors should state this clearly so that readers do not get the impression that data are duplicated.

In the previous version, [Figure 3A](#fig3){ref-type="fig"} in [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"} were indeed the same images. [Figure 3A](#fig3){ref-type="fig"} is to show the expression pattern of Trh (we used strain Trh::Gal4 \> UAS-mCD8GFP), and [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"} is to show expression comparison of Trh::Gal4 (Trh::Gal4 \> UAS-mCD8GFP) and TrhGKO (TrhGKO \> UAS-mCD8GFP). To avoid confusion, we are now using another image of Trh::Gal4 \> UAS-mCD8GFP brain in the revised manuscript.

> Subsection "Manipulation of 5HT2b and dFB intersectional neurons regulates sleep duration and homeostasis", last paragraph: What was the efficiency of FLP-FRT recombination in the intersectional experiments in [Figure 5](#fig5){ref-type="fig"}?

We tested the efficiency of FLP-FRT recombination with immunostaining (23E10-Gal4, 5HT2b-LexA, UAS \> stop\> mCD8GFP, LexAop-Flp). For the 10 brains dissected, 4-8 neurons are labeled with 2-4 neurons on each side of the brain. The efficiency of FLP-FRT recombination is high enough for intersectional neural manipulations.

> Subsection "Manipulation of 5HT2b and dFB intersectional neurons regulates sleep duration and homeostasis", last paragraph: The description of either [Figure 5D](#fig5){ref-type="fig"} or 5E is wrong. The control genotype III shows impaired sleep rebound.

We showed the wrong schematic illustration of strategy in [Figure 5D](#fig5){ref-type="fig"} in our previous manuscript. We have corrected this in the revised manuscript.

> Rescue manipulations in [Figure 6C](#fig6){ref-type="fig"} should probably have a wild-type (no transgene control), as the effects of overexpressing 5HT2B might not be apparent. Finally, some genotypes in [Figure 6](#fig6){ref-type="fig"} are not fully clear. For animals positive for both \"5HT2B mutant\" and \"5HT2B-GKO (genotype III), are these heterozygotes carrying two modified alleles at the 5HT2B locus?

As we had mentioned before, the wt control have white gene on X chromosome and the *w1118* flies are white eye. So we didn't include the wt control in [Figure 6C](#fig6){ref-type="fig"}. The other controls support our conclusions.

The genotypes in [Figure 6](#fig6){ref-type="fig"} are not fully clear. We added the complete genotypes of flies used in each behavioral experiment as [Table 1](#table1){ref-type="table"} in the revised manuscript.

> Earlier work is not correctly cited in various parts of the manuscript (e.g. Becnel et al. 2011, Dierick et al. 2007 are cited as showing 5HT1a mutant flies have altered sleep, but these papers do not report these findings). In addition, the authors should discuss prior work pertinent to their study. For instance, the section on 5HTP feeding should refer to similar experiments done by Yuan et al. (2006) and discuss the possibility that increased sleep in the mutant background results from gain-of-function effects. In addition, findings with 5HT receptor and Trh GAL4 lines should be compared with those if earlier studies (Gnerer et al., 2015; Alekseyenko et al., 2010).

The revised manuscript has correct citations, new citations and discussions of previous work related to our current study.

> The design and structure of alleles is not adequately described. Primer sequences, deletion junctions, et cetera should be described to enable readers to assess the nature of these alleles and validate them independently.

The revised manuscript has an additional table containing detail information for the design and structures of alleles used in the paper, including primer sequences for KI and KO (5' arm and 3' arm design), sgRNA information for CRISPR/CAS9 genome editing.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:
>
> 1\) Genetic controls that were requested in the previous decision letter were not included:
>
> \"Necessary genetic controls are missing for [Figure 5B-C](#fig5){ref-type="fig"} (Undriven UAS-Nachbach and UAS-Hid), 5E-F (Undriven LexAop-Flp, Tub\>Gal80\> & UAS-Hid) & 6B-E (5HT2b mutants with gal4 drivers but no UAS rescue).\"
>
> Undriven UAS-Nachbac/+ and UAS-Hid/+ controls are required for proper interpretation of 5B-C. Data for these lines are included in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} but baseline sleep levels in the other controls between these panels do not appear to be consistent. If the undriven UAS controls from [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} are directly compared to data in [Figure 5C](#fig5){ref-type="fig"}, it is not clear that genotype IV (the expression of Hid in dFB neurons expressing 5HT2b) has a significant decrease in daytime or whole day sleep from UAS-Hid controls or that the night-time sleep in genotype III (expression of NachBac in dFB neurons expressing 5HT2b) is higher than the UAS-Nachbac controls in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}. These results require proper genetic controls to support the author\'s interpretations.

We thank the reviews for the comments. We repeated the experiments and added the necessary controls as requested. In [Figure 5B-C](#fig5){ref-type="fig"}, we now have UAS-Nachbach, UAS-Hid, 23E10-Gal4/5HT2b-LexA and Tub\>Gal80\>/LexAop-Flp controls for activation and ablation of intersectional neurons.

In [Figure 5E-F](#fig5){ref-type="fig"}, we now have UAS-Hid, 23E10-Gal4/5HT2b-LexA and Tub\>Gal80\>/LexAop-Flp for ablation of intersectional neurons. We show the changes in our revised manuscript.

> Additionally, 23E10-GAL4 in a 5HT2b mutant background (with no UAS-5HT2b) is needed for [Figures 6B-C](#fig6){ref-type="fig"}.
>
> Rescue manipulations in [Figure 6C](#fig6){ref-type="fig"} should probably have a wild-type (no transgene control), as the effects of overexpressing 5HT2B might not be apparent.

In [Figure 6B-E](#fig6){ref-type="fig"}, we now have wt, UAS-5HT2b in 5HT2b mutant background and 23E10-Gal4 in mutant background as controls for rescue experiment. We have also rescued in all 5HT2b neurons as positive control. These experiments and RNAi manipulations further support that the 5HT2b gene in 23E10- and 5HT2b- intersectional neurons is necessary and sufficient in sleep regulation.

> Finally, some genotypes in [Figure 6](#fig6){ref-type="fig"} are not fully clear. For animals positive for both \"5HT2B mutant\" and \"5HT2B-GKO (genotype III)\", are these heterozygotes carrying two modified alleles at the 5HT2B locus?

We have now added the complete genotypes of the flies used. For genotype III (w-;UAS-5HT2b/+;5HT2b^GKO^/5HT2b^attp^), it is heterozygotes carrying two modified alleles at the 5HT2B locus, one allele is 5HT2b^GKO^(generated by Strategy II, replaced the gene with Gal4), the other is 5HT2b^attp^ (generated by Strategy I, replaced the gene with Gal4 and then deleted the insertion Gal4 with cre). Genotype III allows us to rescue 5HT2b expression in all 5HT2b neurons.

> 2\) The interpretation of [Figures 4L-N](#fig4){ref-type="fig"} is not clear. These panels show that driving expression of 5HT2b::sfGFP in the dFB labels dFB neurons with GFP. If the authors want to show subcellular localization of 5HT2b in dFB neurons, the best strategy would be imaging 5HT2b::sfGFP protein-trap signal (see [Figure 4I-K](#fig4){ref-type="fig"}) in flies that also contain R23E10-GAL4;UAS-RFP. That combination would permit clear colocalization with endogenous 5HT2b and dFB axons vs dendrites. Otherwise the authors should refrain from commenting on the subcellular location.

We are now clarifying the interpretation of [Figure 4L-N](#fig4){ref-type="fig"}. We detected both strong anti-serotonin immunofluorescence and 5HT2b^sfGFP^ staining signal at dorsal FB region ([Figure 4I-K](#fig4){ref-type="fig"}). There are two concerns. 1) There may be other 5HT2b positive neurons innervating to dFB, not only the ExFl2 neurons (23E10-Gal4 labeled dFB neurons) that promote sleep. 2) GPCRs are usually located at postsynaptic membrane. To determine whether the ExFl2 neurons contribute to the 5HT2bsfGFP staining signal at dorsal FB region, we crossed UAS-5HT2bsfGFP to 23E10-Gal4. We detected subcellular location of 5HT2bsfGFP in ExFl2 neurons. We found strong GFP in the presynaptic region of ExFl2 neurons, but not in the postsynaptic region nor cell body ([Figure 4L-N](#fig4){ref-type="fig"}). These results suggest that 5HT2b receptor is located presynaptically in ExFl2 neurons. We have changed our interpretation of the [Figure 4L-N](#fig4){ref-type="fig"} in our revised manuscript.

> 3\) The manuscript and title state that 5HT2b functions in a \"single pair of neurons\", though the intersectional genetic strategies applied to 5HT2b access perhaps two pairs of neurons. The \"single pair of neurons\" is from a different Gal4/LexA overlap experiment ([Figure 4F](#fig4){ref-type="fig"}), which was not used for experiments involving 5HT2b. This is not a sticking point for the conclusion that 5HT2B functions in a subset of 23E10 neurons, but there is no need to overstate the result in the title and paper.

We have changed the statement of \"single pair of neurons\" into "a small subset" in both manuscript and title.

> 4\) There continue to be a number of errors throughout the revised manuscript (text and figures), including several mentioned in the first round of review. These include mismatched citations to figures in the text (Results), and typographical mistakes. For instance, in the subsection "Genotypes in figures" under [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}, FRT-flanked stop alleles are misspelled as \"Strop\". There are also inconsistencies in the nomenclature.
>
> Note also:
>
> [Figure 1B, C, D](#fig1){ref-type="fig"} are still not legible.
>
> [Figure 1I, J, K](#fig1){ref-type="fig"} are out of order.
>
> [Figure 1---figure supplement 4B](#fig1s4){ref-type="fig"}: in all three panels, legend on x-axis is missing for several genotypes.
>
> For [Figure 2I](#fig2){ref-type="fig"}, the legend can be clarified to indicate that sleep gain is over 24h.

We thank the reviewers and editors for pointing out these. We have corrected the errors mentioned and revised and re-describe the nomenclature in the new manuscript.

[^1]: Cold Spring Harbor Laboratory, Cold Spring Harbor, United States.
